Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease — Stella

Home/Ischemic Heart Disease/

View on ClinicalTrials.gov

Recruiting

Back to Ischemic Heart Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

NYU Langone Health, New York, New York

Key details

Sponsor

NYU Langone Health

Collaborators

National Institutes of Health (NIH)

Enrollment target

~150 participants

Started

January 2024

Primary completion

March 2027

Age range

75 Years – 100 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.